CNSP

Conviction 83HealthcareScan · Tue, Sep 8, 2026

CNSP$5.93+3.49%

ResistanceSupportVol 14Insider buy

Vol MA14 157.92K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

CNS Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.cnspharma.com ↗

Price5.93

Change+3.49%

Gap-1.40%

Rel volume244.61×

Avg volume113.46K

Avg $ vol671.09K

SMA 205.69

SMA 505.36

SMA 2004.83

Price vs 50+10.53%

Price vs 200+22.79%

MA stackbullish

50/200 cross—

Supertrendup · 4.72

RSI (14)56

MACD hist-0.00

MACD crossbear · 1d

Stoch %K / %D65 / 60

ADX (14)19

+DI / −DI17 / 15

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.37%

ADR %6.85%

52w high10.57

52w low2.13

From 52w high-43.90%

Above 52w low+178.40%

New 52w highNo

SqueezeOn · 1d

Bollinger width19.82%

%B0.72

Donchian pos80.60%

Donchian high6.19

Donchian low4.85

AVWAP (52w high)8.22

vs AVWAP high-27.90%

AVWAP (52w low)8.36

vs AVWAP low-29.03%

OBV trendUp

Chaikin MF (20)0.64

Today vs 20d244.61×

Avg vol (14d)157.92K

Avg vol (20d)113.46K

Avg $ vol (20d)671.09K

Market cap8.67M

RS 3m (vs SPY)+10.17%

RS 6m (vs SPY)+80.35%

RS line new highNo

Trend template4/8

Technical rank86.7

1 week-0.84%

1 month+10.22%

3 months+21.27%

6 months+96.36%

1 year-4.20%

YTD+11.89%

P/E-0.55

P/B0.48

P/S—

P/FCF-0.63

EPS-35.75

Div yield—

ROE-87.09%

ROA-72.25%

Debt/Eq0.02

Current5.86

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-6.68%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-10.87M

Revenue—

Net income-2.59M

Gross profit—

Free cash flow-13.83M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.46M

Employees8

ListedFri, Nov 8, 2019

Free float798.55K

Float %98.4%

Short interest12.6K

Days to cover2.9d

Short volume19.2%

Squeeze score32 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction83 / 100

Pattern quality—

Tech rank86.7 / 100

Group rank96 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.19

Support4.83

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CNSP

All disclosures →

No recent disclosed trades by Congress in CNSP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNSP · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Levin Rami CEO and President · Common Stock · 2026-08-14	Exercise	4.75K	—	2026-08-14	2026-08-18
Levin Rami CEO and President · Restricted Stock Units · 2026-08-14	Exercise	4.75K	—	2026-08-14	2026-08-18
Fisher Michal Director · Common Stock · 2026-05-18	Buy	2K	$10K	2026-05-18	2026-08-18
Charles Faith L. Director · Common Stock · 2026-05-18	Buy	7.1K	$34K	2026-05-18	2026-05-20

SEC filings

EDGAR filings in CNSP · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.